Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Morena Porto"'
Autor:
Claudia Crimi, Raffaele Campisi, Giulia Cacopardo, Rossella Intravaia, Santi Nolasco, Morena Porto, Corrado Pelaia, Nunzio Crimi
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 9, Pp 100462- (2020)
Background: Data on mepolizumab in patients with severe eosinophilic asthma (EA) and comorbidities are needed to assess whether randomized controlled trial results are applicable in the real world. Objective: To evaluate real-life effectiveness and t
Externí odkaz:
https://doaj.org/article/7536801ad0e14ac3a3bfd9ef2b0658f0
Autor:
Santi Nolasco, Raffaele Campisi, Rossella Intravaia, Morena Porto, Corrado Pelaia, Nunzio Crimi, Claudia Crimi
Publikováno v:
F1000Research, Vol 9 (2020)
Background: Monoclonal antibodies are a relatively new therapeutic option for patients with severe refractory asthma, which can be used as an add-on to maintenance therapy, reducing the need for systemic corticosteroid usage, improving asthma symptom
Externí odkaz:
https://doaj.org/article/46f1d46af45846f7b62ba8cc1162eae9
Publikováno v:
Faces: Revista de Administração, Vol 21, Iss 1 (2023)
O objetivo deste artigo é utilizar metáforas para entender a trajetória de executivas brasileiras no mercado de trabalho. Foram pesquisadas três metáforas que representam obstáculos que dificultam ou excluem mulheres de cargos de liderança: Mu
Externí odkaz:
https://doaj.org/article/42275c5e237947f39f47ed33a18daecc
Autor:
CIMAGLIO ALVES DE SOUZA, LETÍCIA1 cimaglio.leticia@gmail.com, MORENA PORTO, ROSELI1 roseli.porto@fgv.br, THOMAZ AYRES DA SILVA, MARÍLIA1 ma.ayres24@gmail.com
Publikováno v:
Revista de Administração FACES Journal. jan-mar2022, Vol. 21 Issue 1, p10-28. 19p.
Autor:
Alberto Papi, Nicola Scichilone, Pietro Impellizzeri, Nunzio Crimi, Claudia Crimi, Santi Nolasco, Raffaele Campisi, Bianca Beghe, Morena Porto, Gabriella Guarnieri
Publikováno v:
Airway pharmacology and treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a33efffe7b75e59f4d2bd214cf7d7c39
https://doi.org/10.1183/13993003.congress-2021.pa3743
https://doi.org/10.1183/13993003.congress-2021.pa3743
Autor:
Luigi Macchia, Gabriella Guarnieri, Giulia Scioscia, Morena Porto, Alberto Papi, Bianca Beghe, Nicola Scichilone, Leonardo Antonicelli, Nunzio Crimi, Maria Pia Foschino Barbaro, Santi Nolasco, Raffaele Campisi, Claudia Crimi
Publikováno v:
Journal of Asthma and Allergy
Journal of Asthma and Allergy, Vol Volume 14, Pp 575-583 (2021)
Journal of Asthma and Allergy, Vol Volume 14, Pp 575-583 (2021)
Raffaele Campisi,1 Claudia Crimi,1 Santi Nolasco,2 Bianca Beghè,3 Leonardo Antonicelli,4 Gabriella Guarnieri,5 Nicola Scichilone,6 Morena Porto,2 Luigi Macchia,7 Giulia Scioscia,8 Maria Pia Foschino Barbaro,8 Alberto Papi,9 Nunzio Crimi1,2 1Respirat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87e3ae6b12d790d5377e94306ff89c43
http://hdl.handle.net/10447/537692
http://hdl.handle.net/10447/537692
Autor:
Corrado Pelaia, Santi Nolasco, Raffaele Campisi, Claudia Crimi, Pietro Impellizzeri, Nunzio Crimi, Rossella Intravaia, Morena Porto, Giulia Cacopardo
BackgroundThe association of bronchiectasis (BE) in patients with severe eosinophilic asthma (SEA) is quite frequent. Mepolizumab is a well-recognized treatment for SEA; we aim to evaluate its effectiveness in SEA patients with and without BE in real
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ef43102cd53a06587f5727249b7b71
https://doi.org/10.1101/2020.11.04.20226266
https://doi.org/10.1101/2020.11.04.20226266
Autor:
Morena Porto, Claudia Crimi, Nunzio Crimi, Giulia Cacopardo, Rossella Intravaia, Santi Nolasco, Raffaele Campisi
Publikováno v:
Airway pharmacology and treatment.
Background: Benralizumab reduces eosinophils both in sputum and peripheral blood, oral corticosteroid intake (OCS), improves pulmonary function and asthma control. Association between asthma and bronchiectasis (BE) is quite frequent, particularly in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::720485d8c27f5595cba5b93f40d6a136
https://doi.org/10.1183/13993003.congress-2020.2225
https://doi.org/10.1183/13993003.congress-2020.2225
Autor:
Rossella Intravaia, Claudia Crimi, Nunzio Crimi, Santi Nolasco, Raffaele Campisi, Morena Porto, Corrado Pelaia, Giulia Cacopardo
Publikováno v:
The World Allergy Organization Journal
World Allergy Organization Journal, Vol 13, Iss 9, Pp 100462-(2020)
World Allergy Organization Journal, Vol 13, Iss 9, Pp 100462-(2020)
Background Data on mepolizumab in patients with severe eosinophilic asthma (EA) and comorbidities are needed to assess whether randomized controlled trial results are applicable in the real world. Objective To evaluate real-life effectiveness and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27713da70cbbd437074262031c3fcbc2
https://hdl.handle.net/20.500.11769/552249
https://hdl.handle.net/20.500.11769/552249
Autor:
Rossella Intravaia, Nunzio Crimi, Morena Porto, Claudia Crimi, Santi Nolasco, Raffaele Campisi, Corrado Pelaia
Publikováno v:
F1000Research
Background: Monoclonal antibodies are a relatively new therapeutic option for patients with severe refractory asthma, which can be used as an add-on to maintenance therapy, reducing the need for systemic corticosteroid usage, improving asthma symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8af6352d15acc4657a66b89f9c903dee
https://doi.org/10.12688/f1000research.24603.1
https://doi.org/10.12688/f1000research.24603.1